{"ticker": {"uuid": "0a10da90-393d-44b4-8a20-d4e106ccaad9", "symbol": "VX1", "name": "Vertex Pharmaceuticals Incorporated", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUVTekQtYjFqODVQTUpmWnpTSlBZT3lEWmhDVjhFZEc2dDctNjZXZ0MySENpa01tQS1CLVgtNTB6cGRWNWIyME9BOGhpRGlDYWF2bWYxRHlnbEtmN3FuZUlVT2c5NVhqZlNjSUlVTWxvYUFCX29xUU4wemRLYkhnOFhnOFhBVmJvYVk5Q1VfaW5KLWN0bElGRG9fdmlXZ1VpNjRqR3NTaWlqQVRCOHdLRkUzdTlLblNPOENJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma Stock (US92532F1003): Analyst sentiment and ownership moves keep VRTX in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbVZmZ1E1QlA2bS1lSXZFWVh0S0VYblN5d3FqWFpfcDZqbERuSlpYY0M1aWdfcU9OenZCb0dZT25kSHA5bXBWUkNFYno3aHRrdlNGRF9GN3pKcTRsTzZ1REdGT3ZKNEFMVHp2UUNadjUzX1ZYQmpBM252cEs2cTBZMkJsMzBLM1VMbjY0VldTd05BNnFzZlNZYVVQSWZSdjB3ZWVjOEM3NThtSTFOS2tVUUhjYXJzWllfSW9Wc2Y1WDAyOWItNGRsZg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Extends Pediatric Pipeline As Shares Trade Below Consensus Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNM3pKNG9xZHN4OUxkZ2c1MUVKdmRETGNSUjRSSnQwaHZySVRBTTVldjRmankxNTNzSEE3R2pSbmUtSTJmU2E3Z2YwaklpUWQxVDZScUJqOWZtQXR6akQzVTMzelhzTVdzaGwwekt1MUl2VXVwZ2hPbVB6czh3UHhBZGZjRElBU2ZzNW5SWDZEaDhuRVlVZkRxcXpHYkhPQmkwTTNhakdWb1BXYlZ0WVE?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRWxFWWN4YWJiVXFtSzNneEtya1lidllZZmNGU3o3UUZMYU9nQUs1aEhsU1Vtc3I0ejVrLUladllOb2dGOS1WdUEwa3poZW42M0dsOHI0dVdpVUMxZW5tTTY3UWR3NEdNLUxUcEpVTVdtOVRtMDJudHZWQVFrNTBHRU9JSlB5WEJjUUZFRHZtU29CUVc1d1lnaWFGakRvdVRmMmZXWU1STlNOaXp4M1FmR1JoTlFQdVdfbWZFLVBsODM0ZVNVbF9sUjgzQkhscWRMQ2QwanU2UVhEazNOQmp6Y1VlYW0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNZlU2a1pxZEpVMzk5dTQwTEJfSV9yT002UU8wVjFRVWFsdVRacGFrdHR5VnBhazBWNzFmNWZzaDNRMUNfTzk3cFpkSGdhY1g1TV9UcTdVdkhuV1F1aXIwTGNHbERPRmZtOHBHTzN1TlBZQ0tiRWpKSmE1aHJGSXIyYU9oVDJ4SmUtWUtrenU5Zw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex\u2019s Germany CASGEVY Deal Highlights Growing Non CF Growth Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdnlaTmhkSEJZaWt2RG9tOGFxNFloV1ZmdnUtNjJaQ0hvXzBJTzhoS2xnZ0pBV3lnbWw3QW9pVVhyRlJ6VzFNSkhTdzBYUkZadHFXNUR1YkNoOGpBUWhxcnNJQWZMMlNMZS1DRndQRU1CNklQdXJxbkhvWUlaODJfeElyeEVLcVpWdU90cktDVmduTVBkbG9HUUxub3M1Z3B0SlU4RFFFR1hTUzA?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZXoxUkxyUWs4SjJ4SWV0U2kxTGppTUp5NExDUk1ISnNWRXhzSWxuVjRqSW5CbEFXQjFyTHNfZm9nZXl1REN1VERWZHE4cVRKNllURWNTXzBzY21YaEEzVVA4Tm8zazJiT0JzTWlWQzRVZWFyVW04Rk54dVVoVFVheTdrakVVTjQ0cEFiZ2N1dnczOS10eHdaVWdrSnlRM1pRT1NHTEpoblk4T1p6V0UyM1hpdml1MElR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces CASGEVY\u00ae Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxOQjJhRVozUlRiRF8wQVdWUFByX3E4bmNNTkVhQTNGaUlhdHNVWHkzZllWWkNSMkJsQldicGdDRmxWUWQtb2hCdUwyNVd4R0lRcnJkSWc5SVZNVWlSY09DWlJLbmN1OFZueVdERktQY1ZHVlI5TmNJWHJ1SXZDZWRkQk1BcTAtVExqbE9qbjRoUnJqU05mSHZVVlNTV0lTSTNramhGTF9rRDRmV2lqMGw0dGFra0VxMTgxck9Wa2lVWWVJS0duT0h4azlRUkY3bkU3NmpURk5zdmRWNDhOLTVnM1ViZjhyRGpaeFRYUFBHU2htU2djN2ViTm5qalQ1elJ6WWlUajh2ekhqQXNQYWRsUGxlSEJfWHdwWUNjZlRYaTk4MHN2RHhF?oc=5", "source_name": "Business Wire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex secures German reimbursement deal for gene therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOVzJrdWVjdXkyX1JCTWVxajQxOGc2ZzRjQW80QXNYWmc5Vjl5c3cxLVpScXB1T1UtZ0l4X19CRTg0cS1Hb1FxaDZTandNNUZuWkxsNWtkTW1PcEhFTWJycWNRa3Vjcm5uVlhxbWdvX0ZIMFlpdXBqQU5mRXVUcm1vTk9HQWJLV1lHZ051WG4zSVNDd3NhU3NnUnlCaGZIT2NJMnVwNzRHdUh1YWg2UktWcHAwMVo?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRWFOTVJScjVfeFpiVTZmc2hTeXlYcGZrcTQzOVJ4Zm56Q3R0TUZNekFxT2ctOG90ZEJVRng5OVFaZ2JFQmNaaXBLazVPZTNaNDUxS0JhdEotYXlYMTR5aC1ocFo4REoxeVBkOUU1bEF3Q2tuSkxvYUh0aUxwSWh0ZlFfdkcwMHlNNUNxRGE0dVMzd1lfRC14TFppTzNaU3BtWk03Tl9hZ1Q1VEVt?oc=5", "source_name": "Business Wire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Stocks Are Today\u2019s Movers: BioNTech, NIO, Centene, Vertex, Paramount, Rivian, Occidental, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE9MOTBpZGVNVEFKaUYwMmhsWTNpZnR0RDBmOHozM1lnbnRWQkYySHcwMjMyM3djMFVkRHJuRXQtRWN1OHBCbkoxb3JkOElqU0U2ajZVdldoWWtxNS1Ma2VWTG1LbU4?oc=5", "source_name": "Barron's", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMmxYWmJfSEZ6cHFraDJySHJPZzVJckFmYjBWZFVReDU3UXBva01yTU9hcWRLdVl3WnVUS1kxZENPNW1xR0t0Y05SRi1JYkg1VzM2ck55V0p6dzU5SGpuem1CcU1PSkZCcVByMVdjc0hQX3ZqTkVwX3M2Vlg5U3UzelkyM0thVGFmS0VaM01mTFZMRFhZWjRXWDFjbFVvdGpPM196bGl3U3VubjQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUVTekQtYjFqODVQTUpmWnpTSlBZT3lEWmhDVjhFZEc2dDctNjZXZ0MySENpa01tQS1CLVgtNTB6cGRWNWIyME9BOGhpRGlDYWF2bWYxRHlnbEtmN3FuZUlVT2c5NVhqZlNjSUlVTWxvYUFCX29xUU4wemRLYkhnOFhnOFhBVmJvYVk5Q1VfaW5KLWN0bElGRG9fdmlXZ1VpNjRqR3NTaWlqQVRCOHdLRkUzdTlLblNPOENJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma Stock (US92532F1003): Analyst sentiment and ownership moves keep VRTX in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbVZmZ1E1QlA2bS1lSXZFWVh0S0VYblN5d3FqWFpfcDZqbERuSlpYY0M1aWdfcU9OenZCb0dZT25kSHA5bXBWUkNFYno3aHRrdlNGRF9GN3pKcTRsTzZ1REdGT3ZKNEFMVHp2UUNadjUzX1ZYQmpBM252cEs2cTBZMkJsMzBLM1VMbjY0VldTd05BNnFzZlNZYVVQSWZSdjB3ZWVjOEM3NThtSTFOS2tVUUhjYXJzWllfSW9Wc2Y1WDAyOWItNGRsZg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Extends Pediatric Pipeline As Shares Trade Below Consensus Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNM3pKNG9xZHN4OUxkZ2c1MUVKdmRETGNSUjRSSnQwaHZySVRBTTVldjRmankxNTNzSEE3R2pSbmUtSTJmU2E3Z2YwaklpUWQxVDZScUJqOWZtQXR6akQzVTMzelhzTVdzaGwwekt1MUl2VXVwZ2hPbVB6czh3UHhBZGZjRElBU2ZzNW5SWDZEaDhuRVlVZkRxcXpHYkhPQmkwTTNhakdWb1BXYlZ0WVE?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRWxFWWN4YWJiVXFtSzNneEtya1lidllZZmNGU3o3UUZMYU9nQUs1aEhsU1Vtc3I0ejVrLUladllOb2dGOS1WdUEwa3poZW42M0dsOHI0dVdpVUMxZW5tTTY3UWR3NEdNLUxUcEpVTVdtOVRtMDJudHZWQVFrNTBHRU9JSlB5WEJjUUZFRHZtU29CUVc1d1lnaWFGakRvdVRmMmZXWU1STlNOaXp4M1FmR1JoTlFQdVdfbWZFLVBsODM0ZVNVbF9sUjgzQkhscWRMQ2QwanU2UVhEazNOQmp6Y1VlYW0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNZlU2a1pxZEpVMzk5dTQwTEJfSV9yT002UU8wVjFRVWFsdVRacGFrdHR5VnBhazBWNzFmNWZzaDNRMUNfTzk3cFpkSGdhY1g1TV9UcTdVdkhuV1F1aXIwTGNHbERPRmZtOHBHTzN1TlBZQ0tiRWpKSmE1aHJGSXIyYU9oVDJ4SmUtWUtrenU5Zw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex\u2019s Germany CASGEVY Deal Highlights Growing Non CF Growth Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdnlaTmhkSEJZaWt2RG9tOGFxNFloV1ZmdnUtNjJaQ0hvXzBJTzhoS2xnZ0pBV3lnbWw3QW9pVVhyRlJ6VzFNSkhTdzBYUkZadHFXNUR1YkNoOGpBUWhxcnNJQWZMMlNMZS1DRndQRU1CNklQdXJxbkhvWUlaODJfeElyeEVLcVpWdU90cktDVmduTVBkbG9HUUxub3M1Z3B0SlU4RFFFR1hTUzA?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZXoxUkxyUWs4SjJ4SWV0U2kxTGppTUp5NExDUk1ISnNWRXhzSWxuVjRqSW5CbEFXQjFyTHNfZm9nZXl1REN1VERWZHE4cVRKNllURWNTXzBzY21YaEEzVVA4Tm8zazJiT0JzTWlWQzRVZWFyVW04Rk54dVVoVFVheTdrakVVTjQ0cEFiZ2N1dnczOS10eHdaVWdrSnlRM1pRT1NHTEpoblk4T1p6V0UyM1hpdml1MElR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Announces CASGEVY\u00ae Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxOQjJhRVozUlRiRF8wQVdWUFByX3E4bmNNTkVhQTNGaUlhdHNVWHkzZllWWkNSMkJsQldicGdDRmxWUWQtb2hCdUwyNVd4R0lRcnJkSWc5SVZNVWlSY09DWlJLbmN1OFZueVdERktQY1ZHVlI5TmNJWHJ1SXZDZWRkQk1BcTAtVExqbE9qbjRoUnJqU05mSHZVVlNTV0lTSTNramhGTF9rRDRmV2lqMGw0dGFra0VxMTgxck9Wa2lVWWVJS0duT0h4azlRUkY3bkU3NmpURk5zdmRWNDhOLTVnM1ViZjhyRGpaeFRYUFBHU2htU2djN2ViTm5qalQ1elJ6WWlUajh2ekhqQXNQYWRsUGxlSEJfWHdwWUNjZlRYaTk4MHN2RHhF?oc=5", "source_name": "Business Wire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex secures German reimbursement deal for gene therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOVzJrdWVjdXkyX1JCTWVxajQxOGc2ZzRjQW80QXNYWmc5Vjl5c3cxLVpScXB1T1UtZ0l4X19CRTg0cS1Hb1FxaDZTandNNUZuWkxsNWtkTW1PcEhFTWJycWNRa3Vjcm5uVlhxbWdvX0ZIMFlpdXBqQU5mRXVUcm1vTk9HQWJLV1lHZ051WG4zSVNDd3NhU3NnUnlCaGZIT2NJMnVwNzRHdUh1YWg2UktWcHAwMVo?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRWFOTVJScjVfeFpiVTZmc2hTeXlYcGZrcTQzOVJ4Zm56Q3R0TUZNekFxT2ctOG90ZEJVRng5OVFaZ2JFQmNaaXBLazVPZTNaNDUxS0JhdEotYXlYMTR5aC1ocFo4REoxeVBkOUU1bEF3Q2tuSkxvYUh0aUxwSWh0ZlFfdkcwMHlNNUNxRGE0dVMzd1lfRC14TFppTzNaU3BtWk03Tl9hZ1Q1VEVt?oc=5", "source_name": "Business Wire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Stocks Are Today\u2019s Movers: BioNTech, NIO, Centene, Vertex, Paramount, Rivian, Occidental, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE9MOTBpZGVNVEFKaUYwMmhsWTNpZnR0RDBmOHozM1lnbnRWQkYySHcwMjMyM3djMFVkRHJuRXQtRWN1OHBCbkoxb3JkOElqU0U2ajZVdldoWWtxNS1Ma2VWTG1LbU4?oc=5", "source_name": "Barron's", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMmxYWmJfSEZ6cHFraDJySHJPZzVJckFmYjBWZFVReDU3UXBva01yTU9hcWRLdVl3WnVUS1kxZENPNW1xR0t0Y05SRi1JYkg1VzM2ck55V0p6dzU5SGpuem1CcU1PSkZCcVByMVdjc0hQX3ZqTkVwX3M2Vlg5U3UzelkyM0thVGFmS0VaM01mTFZMRFhZWjRXWDFjbFVvdGpPM196bGl3U3VubjQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 17, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 12, "score": 52, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 4.55, "count": 7}, {"event": "earnings", "label": "Earnings", "weight": 2.55, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.45, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 425.6, "latest_week": "2026-07-10", "one_week_move": -7.2, "four_week_move": 11.3, "twelve_week_move": 14.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.162766, "market_dynamics_buy_signal": false, "relative_strength": 8.480162, "fair_value_gap": 8.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.9212, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.2% over one week, +11.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Seeking Alpha", "count": 3}, {"label": "Market source", "count": 3}, {"label": "IndexBox", "count": 2}, {"label": "Business Wire", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "The Motley Fool", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "Investing.com Australia", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Earnings", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-7.2% over one week, +11.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)"}], "updated_at": "2026-07-17T18:58:46.991093+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}